ABBOTT LABORATORIES Capital Expenditures
ABBOTT LABORATORIES (ABT) reported Capital Expenditures of $399.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-04-29
- ABBOTT LABORATORIES payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $399.00M, a 17.56% decline year-over-year.
- ABBOTT LABORATORIES payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $689.00M, a 4.31% decline year-over-year.
- ABBOTT LABORATORIES payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $496.00M, a 10.79% decline year-over-year.
- ABBOTT LABORATORIES payments to acquire property, plant, and equipment for the quarter ending 2025-06-30 was $502.00M, a 5.82% decline year-over-year.
- ABBOTT LABORATORIES payments to acquire property, plant, and equipment for fiscal 2025 was $2.17B, a 1.63% decline from fiscal 2024.
- ABBOTT LABORATORIES payments to acquire property, plant, and equipment for fiscal 2024 was $2.21B, a 0.23% increase from fiscal 2023.
- ABBOTT LABORATORIES payments to acquire property, plant, and equipment for fiscal 2023 was $2.20B, a 23.92% increase from fiscal 2022.
- ABBOTT LABORATORIES payments to acquire property, plant, and equipment for fiscal 2022 was $1.78B, a 5.73% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 3 month as first filed | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $399.00M 10-Q · filed 2026-04-29 | $1.09B derived: sum of 2 quarters · filed 2026-04-29 | $1.58B derived: sum of 3 quarters · filed 2026-04-29 | $2.09B derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-12-31 | $689.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $1.19B derived: sum of 2 quarters · filed 2026-02-20 | $1.69B derived: sum of 3 quarters · filed 2026-02-20 | $2.17B 10-K · filed 2026-02-20 | ||||
| 2025-09-30 | $496.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $998.00M derived: sum of 2 quarters · filed 2025-10-29 | $1.48B 10-Q · filed 2025-10-29 | $2.20B derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-06-30 | $502.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $986.00M 10-Q · filed 2025-07-30 | $1.71B derived: sum of 3 quarters · filed 2026-04-29 | $2.26B derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2025-03-31 | $484.00M 10-Q · filed 2026-04-29 | $1.20B derived: sum of 2 quarters · filed 2026-04-29 | $1.76B derived: sum of 3 quarters · filed 2026-04-29 | $2.29B derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | $720.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $1.28B derived: sum of 2 quarters · filed 2026-02-20 | $1.81B derived: sum of 3 quarters · filed 2026-02-20 | $2.21B 10-K · filed 2026-02-20 | ||||
| 2024-09-30 | $556.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $1.09B derived: sum of 2 quarters · filed 2025-10-29 | $1.49B 10-Q · filed 2025-10-29 | $2.24B derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2024-06-30 | $533.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $931.00M 10-Q · filed 2025-07-30 | $1.69B derived: sum of 3 quarters · filed 2026-02-20 | $2.25B derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2024-03-31 | $398.00M 10-Q · filed 2025-04-30 | $1.15B derived: sum of 2 quarters · filed 2026-02-20 | $1.71B derived: sum of 3 quarters · filed 2026-02-20 | $2.22B derived: sum of 4 quarters · filed 2026-02-20 | ||||
| 2023-12-31 | $755.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $1.31B derived: sum of 2 quarters · filed 2026-02-20 | $1.82B derived: sum of 3 quarters · filed 2026-02-20 | $2.20B 10-K · filed 2026-02-20 | ||||
| 2023-09-30 | $560.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $1.07B derived: sum of 2 quarters · filed 2024-10-31 | $1.45B 10-Q · filed 2024-10-31 | $2.06B derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2023-06-30 | $507.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $887.00M 10-Q · filed 2024-07-31 | $1.50B derived: sum of 3 quarters · filed 2025-02-21 | $1.96B derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2023-03-31 | $380.00M 10-Q · filed 2024-05-02 | $990.00M derived: sum of 2 quarters · filed 2025-02-21 | $1.46B derived: sum of 3 quarters · filed 2025-02-21 | $1.84B derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2022-12-31 | $610.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $1.08B derived: sum of 2 quarters · filed 2025-02-21 | $1.46B derived: sum of 3 quarters · filed 2025-02-21 | $1.78B 10-K · filed 2025-02-21 | ||||
| 2022-09-30 | $467.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $846.00M derived: sum of 2 quarters · filed 2023-11-01 | $1.17B 10-Q · filed 2023-11-01 | $1.78B derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2022-06-30 | $379.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $700.00M 10-Q · filed 2023-08-03 | $1.31B derived: sum of 3 quarters · filed 2024-02-16 | $1.77B derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2022-03-31 | $321.00M 10-Q · filed 2023-05-04 | $935.00M derived: sum of 2 quarters · filed 2024-02-16 | $1.40B derived: sum of 3 quarters · filed 2024-02-16 | $1.81B derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2021-12-31 | $614.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | $1.07B derived: sum of 2 quarters · filed 2024-02-16 | $1.49B derived: sum of 3 quarters · filed 2024-02-16 | $1.89B 10-K · filed 2024-02-16 | ||||
| 2021-09-30 | $461.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $874.00M derived: sum of 2 quarters · filed 2022-11-01 | $1.27B 10-Q · filed 2022-11-01 | $1.95B derived: sum of 4 quarters · filed 2023-02-17 | ||||
| 2021-06-30 | $413.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $810.00M 10-Q · filed 2022-08-02 | $1.49B derived: sum of 3 quarters · filed 2023-02-17 | $1.99B derived: sum of 4 quarters · filed 2023-02-17 | ||||
| 2021-03-31 | $397.00M 10-Q · filed 2022-05-03 | $1.08B derived: sum of 2 quarters · filed 2023-02-17 | $1.57B derived: sum of 3 quarters · filed 2023-02-17 | $2.21B derived: sum of 4 quarters · filed 2023-02-17 | ||||
| 2020-12-31 | $679.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17 | $1.18B derived: sum of 2 quarters · filed 2023-02-17 | $1.82B derived: sum of 3 quarters · filed 2023-02-17 | $2.18B 10-K · filed 2023-02-17 | ||||
| 2020-09-30 | $496.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $1.14B derived: sum of 2 quarters · filed 2021-11-03 | $1.50B 10-Q · filed 2021-11-03 | $1.93B derived: sum of 4 quarters · filed 2022-02-18 | ||||
| 2020-06-30 | $642.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $1.00B 10-Q · filed 2021-08-04 | $1.44B derived: sum of 3 quarters · filed 2022-02-18 | $1.84B derived: sum of 4 quarters · filed 2022-02-18 | ||||
| 2020-03-31 | $360.00M 10-Q · filed 2021-05-05 | $794.00M derived: sum of 2 quarters · filed 2022-02-18 | $1.20B derived: sum of 3 quarters · filed 2022-02-18 | $1.66B derived: sum of 4 quarters · filed 2022-02-18 | ||||
| 2019-12-31 | $434.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $835.00M derived: sum of 2 quarters · filed 2022-02-18 | $1.30B derived: sum of 3 quarters · filed 2022-02-18 | $1.64B 10-K · filed 2022-02-18 | ||||
| 2019-09-30 | $401.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $869.00M derived: sum of 2 quarters · filed 2020-11-04 | $1.20B 10-Q · filed 2020-11-04 | $1.67B derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2019-06-30 | $468.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $803.00M 10-Q · filed 2020-07-29 | $1.27B derived: sum of 3 quarters · filed 2021-02-19 | $1.62B derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2019-03-31 | $335.00M 10-Q · filed 2020-04-29 | $802.00M derived: sum of 2 quarters · filed 2021-02-19 | $1.16B derived: sum of 3 quarters · filed 2021-02-19 | $1.45B derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2018-12-31 | $467.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $821.00M derived: sum of 2 quarters · filed 2021-02-19 | $1.12B derived: sum of 3 quarters · filed 2021-02-19 | $1.39B 10-K · filed 2021-02-19 | ||||
| 2018-09-30 | $354.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $652.00M derived: sum of 2 quarters · filed 2019-10-31 | $927.00M 10-Q · filed 2019-10-31 | $1.27B derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2018-06-30 | $298.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $573.00M 10-Q · filed 2019-07-31 | $918.00M derived: sum of 3 quarters · filed 2020-02-21 | $1.18B derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2018-03-31 | $275.00M 10-Q · filed 2019-05-01 | $620.00M derived: sum of 2 quarters · filed 2020-02-21 | $883.00M derived: sum of 3 quarters · filed 2020-02-21 | $1.14B derived: sum of 4 quarters · filed 2020-02-21 | ||||
| 2017-12-31 | $345.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $608.00M derived: sum of 2 quarters · filed 2020-02-21 | $863.00M derived: sum of 3 quarters · filed 2020-02-21 | $1.14B 10-K · filed 2020-02-21 | ||||
| 2017-09-30 | $263.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $518.00M derived: sum of 2 quarters · filed 2018-10-31 | $790.00M 10-Q · filed 2018-10-31 | $1.11B derived: sum of 4 quarters · filed 2019-02-22 | ||||
| 2017-06-30 | $255.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $527.00M 10-Q · filed 2018-08-01 | $846.00M derived: sum of 3 quarters · filed 2019-02-22 | $1.16B derived: sum of 4 quarters · filed 2019-02-22 | ||||
| 2017-03-31 | $272.00M 10-Q · filed 2018-05-02 | $591.00M derived: sum of 2 quarters · filed 2019-02-22 | $903.00M derived: sum of 3 quarters · filed 2019-02-22 | $1.15B derived: sum of 4 quarters · filed 2019-02-22 | ||||
| 2016-12-31 | $319.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $631.00M derived: sum of 2 quarters · filed 2019-02-22 | $878.00M derived: sum of 3 quarters · filed 2019-02-22 | $1.12B 10-K · filed 2019-02-22 | ||||
| 2016-09-30 | $312.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $559.00M derived: sum of 2 quarters · filed 2017-11-02 | $802.00M 10-Q · filed 2017-11-02 | $1.05B derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2016-06-30 | $247.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $490.00M 10-Q · filed 2017-08-02 | $738.00M derived: sum of 3 quarters · filed 2018-02-16 | $1.15B derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2016-03-31 | $243.00M 10-Q · filed 2017-05-03 | $491.00M derived: sum of 2 quarters · filed 2018-02-16 | $902.00M derived: sum of 3 quarters · filed 2018-02-16 | $1.12B derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2015-12-31 | $248.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $659.00M derived: sum of 2 quarters · filed 2018-02-16 | $875.00M derived: sum of 3 quarters · filed 2018-02-16 | $1.11B 10-K · filed 2018-02-16 | ||||
| 2015-09-30 | $411.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $627.00M derived: sum of 2 quarters · filed 2016-11-03 | $862.00M 10-Q · filed 2016-11-03 | $1.15B derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-06-30 | $216.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $451.00M 10-Q · filed 2016-08-03 | $738.00M derived: sum of 3 quarters · filed 2017-02-17 | $1.01B derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-03-31 | $235.00M 10-Q · filed 2016-05-04 | $522.00M derived: sum of 2 quarters · filed 2017-02-17 | $799.00M derived: sum of 3 quarters · filed 2017-02-17 | $1.06B derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2014-12-31 | $287.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $564.00M derived: sum of 2 quarters · filed 2017-02-17 | $822.00M derived: sum of 3 quarters · filed 2017-02-17 | $1.08B 10-K · filed 2017-02-17 | ||||
| 2014-09-30 | $277.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $535.00M derived: sum of 2 quarters · filed 2015-11-05 | $790.00M 10-Q · filed 2015-11-05 | $1.09B derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-06-30 | $258.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $513.00M 10-Q · filed 2015-08-04 | $816.00M derived: sum of 3 quarters · filed 2016-02-19 | $1.09B derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-03-31 | $255.00M 10-Q · filed 2015-05-06 | $558.00M derived: sum of 2 quarters · filed 2016-02-19 | $835.00M derived: sum of 3 quarters · filed 2016-02-19 | $1.13B derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2013-12-31 | $303.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $580.00M derived: sum of 2 quarters · filed 2016-02-19 | $871.00M derived: sum of 3 quarters · filed 2016-02-19 | $1.15B 10-K · filed 2016-02-19 | ||||
| 2013-09-30 | $277.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $568.00M derived: sum of 2 quarters · filed 2014-11-06 | $842.00M 10-Q · filed 2014-11-06 | $841.34M 10-Q · filed 2013-11-07 | $1.23B derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2013-06-30 | $291.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $565.00M 10-Q · filed 2014-08-05 | $564.88M 10-Q · filed 2013-08-06 | $950.81M derived: sum of 3 quarters · filed 2015-02-27 | $1.48B derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2013-03-31 | $274.00M 10-Q · filed 2014-05-07 | $274.46M 10-Q · filed 2013-05-08 | $659.81M derived: sum of 2 quarters · filed 2015-02-27 | $1.19B derived: sum of 3 quarters · filed 2015-02-27 | $1.62B derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2012-12-31 | $385.81M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $916.55M derived: sum of 2 quarters · filed 2015-02-27 | $1.34B derived: sum of 3 quarters · filed 2015-02-27 | $1.79B 10-K · filed 2015-02-27 | $1.80B 10-K · filed 2013-02-15 | |||
| 2012-09-30 | $530.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $955.86M derived: sum of 2 quarters · filed 2013-11-07 | $1.41B 10-Q · filed 2013-11-07 | $1.68B derived: sum of 4 quarters · filed 2014-02-21 | ||||
| 2012-06-30 | $425.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $878.45M 10-Q · filed 2013-08-06 | $1.15B derived: sum of 3 quarters · filed 2014-02-21 | $1.60B derived: sum of 4 quarters · filed 2014-02-21 | ||||
| 2012-03-31 | $453.33M 10-Q · filed 2013-05-08 | $727.57M derived: sum of 2 quarters · filed 2014-02-21 | $1.18B derived: sum of 3 quarters · filed 2014-02-21 | $1.55B derived: sum of 4 quarters · filed 2014-02-21 | ||||
| 2011-12-31 | $274.24M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $726.23M derived: sum of 2 quarters · filed 2014-02-21 | $1.10B derived: sum of 3 quarters · filed 2014-02-21 | $1.49B 10-K · filed 2014-02-21 | $1.49B 10-K · filed 2012-02-21 | |||
| 2011-09-30 | $452.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $824.95M derived: sum of 2 quarters · filed 2012-11-07 | $1.22B 10-Q · filed 2012-11-07 | $1.51B derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2011-06-30 | $372.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $764.77M 10-Q · filed 2012-08-07 | $1.06B derived: sum of 3 quarters · filed 2013-02-15 | $1.26B derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2011-03-31 | $391.81M 10-Q · filed 2012-05-08 | $683.15M derived: sum of 2 quarters · filed 2013-02-15 | $888.23M derived: sum of 3 quarters · filed 2013-02-15 | $1.16B derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2010-12-31 | $291.33M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | $496.42M derived: sum of 2 quarters · filed 2013-02-15 | $769.93M derived: sum of 3 quarters · filed 2013-02-15 | $1.02B 10-K · filed 2013-02-15 | ||||
| 2010-09-30 | $205.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $478.60M derived: sum of 2 quarters · filed 2011-11-04 | $723.74M 10-Q · filed 2011-11-04 | $969.19M derived: sum of 4 quarters · filed 2012-02-21 | ||||
| 2010-06-30 | $273.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | $518.66M 10-Q · filed 2011-08-04 | $764.10M derived: sum of 3 quarters · filed 2012-02-21 | $1.09B derived: sum of 4 quarters · filed 2012-02-21 | ||||
| 2010-03-31 | $245.14M 10-Q · filed 2011-05-06 | $490.59M derived: sum of 2 quarters · filed 2012-02-21 | $819.30M derived: sum of 3 quarters · filed 2012-02-21 | $1.08B derived: sum of 4 quarters · filed 2012-02-21 | ||||
| 2009-12-31 | $245.45M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-21 | $574.16M derived: sum of 2 quarters · filed 2012-02-21 | $836.90M derived: sum of 3 quarters · filed 2012-02-21 | $1.09B 10-K · filed 2012-02-21 | ||||
| 2009-09-30 | $328.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | $591.45M derived: sum of 2 quarters · filed 2010-11-05 | $843.60M 10-Q · filed 2010-11-05 | $1.11B derived: sum of 4 quarters · filed 2011-02-18 | ||||
| 2009-06-30 | $262.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-05 | $514.89M 10-Q · filed 2010-08-05 | $779.48M derived: sum of 3 quarters · filed 2011-02-18 | $1.10B derived: sum of 4 quarters · filed 2011-02-18 | ||||
| 2009-03-31 | $252.15M 10-Q · filed 2010-05-04 | $516.74M derived: sum of 2 quarters · filed 2011-02-18 | $836.55M derived: sum of 3 quarters · filed 2011-02-18 | |||||
| 2008-12-31 | $264.59M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-18 | $584.40M derived: sum of 2 quarters · filed 2011-02-18 | $1.29B 10-K · filed 2011-02-18 | |||||
| 2008-09-30 | $319.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-06 | $1.02B 10-Q · filed 2009-11-06 | ||||||
| 2008-06-30 | $703.33M 10-Q · filed 2009-08-07 | |||||||
| 2007-12-31 | $1.66B 10-K · filed 2010-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |